Reference Listed Drugs (RLDs)
At AksharAvira Pharma, we understand the critical role RLDs play in your research—whether for bioequivalence studies, ANDA (Abbreviated New Drug Application) submissions, or formulation reverse engineering. That’s why we’ve built a global sourcing network to deliver authentic, traceable RLDs with unmatched reliability.
“Avoid delays: Partner with an RLD supplier that knows global compliance.”
- Global Reach, Local Expertise – Source FDA/EMA/WHO-listed RLDs from 30+ countries, even hard-to-find products.
- Navigate regional regulations seamlessly (e.g., EU-GMP, US Orange Book standards).
- End-to-End Compliance – Full documentation: Certificates of Analysis (CoA), batch records, and import/export licences.
- Strict cold-chain logistics for temperature-sensitive RLDs.
- Strategic Support – Confused about RLD selection for complex generics? Our team advises on optimal comparator drugs.
- Custom sourcing for obscure markets (e.g., Japan’s “Orange Guide” drugs).
List Of Options
1
FDA/EMA/WHO-listed drugs | Hard-to-find in markets
2
Full documentation (CoA, GMP certs, batch records) | Import/export licensing support
3
Urgent delivery | Cold-chain logistics for biologics
4
Expert guidance for ANDA/bioequivalence studies
5
Obsolete product sourcing | Multi-country RLD procurement
